SLC25A15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.813400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.253000E-01
Normal-vs-Stage2
5.874800E-01
Normal-vs-Stage3
1.547040E-01
Normal-vs-Stage4
6.891400E-01
Stage1-vs-Stage2
9.030400E-01
Stage1-vs-Stage3
2.620000E-01
Stage1-vs-Stage4
9.202400E-01
Stage2-vs-Stage3
1.279170E-01
Stage2-vs-Stage4
9.471200E-01
Stage3-vs-Stage4
3.112800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.741400E-01
Normal-vs-AfricanAmerican
3.117800E-01
Normal-vs-Asian
9.989400E-01
Caucasian-vs-AfricanAmerican
2.359800E-01
Caucasian-vs-Asian
4.335600E-01
AfricanAmerican-vs-Asian
2.296600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.988200E-01
Normal-vs-Female
6.713400E-01
Male-vs-Female
8.462400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.160200E-01
Normal-vs-Age(41-60Yrs)
2.642200E-01
Normal-vs-Age(61-80Yrs)
6.738000E-01
Normal-vs-Age(81-100Yrs)
4.319800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.539800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.648400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.115800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.973400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.802200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.207800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.924800E-01
Normal-vs-Daily Drinker
7.351000E-01
Normal-vs-Weekly Drinker
4.395400E-01
Normal-vs-Occasional Drinker
8.243600E-01
Normal-vs-Social Drinker
5.692400E-01
Non Drinker-vs-Daily Drinker
3.946300E-02
Non Drinker-vs-Weekly Drinker
6.791800E-01
Non Drinker-vs-Occasional Drinker
5.570600E-01
Non Drinker-vs-Social Drinker
7.776000E-01
Daily Drinker-vs-Weekly Drinker
5.742000E-02
Daily Drinker-vs-Occasional Drinker
3.071400E-01
Daily Drinker-vs-Social Drinker
9.397600E-02
Weekly Drinker-vs-Occasional Drinker
4.639200E-01
Weekly Drinker-vs-Social Drinker
9.741800E-01
Occasional Drinker-vs-Social Drinker
5.242800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.254400E-01
Normal-vs-Grade 2
4.804200E-01
Normal-vs-Grade 3
3.096000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.958800E-01
Grade 1-vs-Grade 3
1.546210E-01
Grade 1-vs-Grade 4
6.254400E-01
Grade 2-vs-Grade 3
4.859800E-01
Grade 2-vs-Grade 4
4.804200E-01
Grade 3-vs-Grade 4
3.096000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.847400E-01
Normal-vs-NonDiabetic
6.842600E-01
Diabetic-vs-NonDiabetic
4.110200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.991600E-01
Normal-vs-NoPancreatitis
7.344600E-01
Pancreatitis-vs-NoPancreatitis
9.556800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.585200E-01
Normal-vs-N1
5.610200E-01
N0-vs-N1
7.106000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.324200E-01
Normal-vs-TP53-NonMutant
4.902200E-01
TP53-Mutant-vs-TP53-NonMutant
8.129800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
